Results 21 to 30 of about 37,458 (290)

Changes and Response Predictive Values of Serum miR-210 and miR-181a in Stable Chronic Obstructive Pulmonary Disease Patients Treated with Glucocorticoid Therapy [PDF]

open access: yesZhongguo quanke yixue, 2022
Background There are rare studies assessing the efficacy of inhaled glucocorticoids (ICS) , the common therapy for chronic obstructive pulmonary disease (COPD) .
Ke QIN, Tonglin LI, Shuai GONG, Meifang JIANG
doaj   +1 more source

MicroRNA-210 Suppresses Junction Proteins and Disrupts Blood-Brain Barrier Integrity in Neonatal Rat Hypoxic-Ischemic Brain Injury. [PDF]

open access: yes, 2017
Cerebral edema, primarily caused by disruption of the blood-brain barrier (BBB), is one of the serious complications associated with brain injury in neonatal hypoxic-ischemic encephalopathy (HIE).
Dasgupta, Chiranjib   +4 more
core   +5 more sources

miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma. [PDF]

open access: yesACS Omega
Pancreatic ductal adenocarcinoma (PDAC) is one among the most lethal malignancies due to its aggressive behavior and resistance to conventional therapies. Hypoxia significantly contributes to cancer progression and therapeutic resistance of PDAC. microRNAs (miRNAs/miRs) have emerged as critical regulators of various biological processes.
Mortoglou M   +4 more
europepmc   +4 more sources

MiR‐210: an important player in the pathogenesis of preeclampsia? [PDF]

open access: yesJournal of Cellular and Molecular Medicine, 2012
Hypoxia is a common feature in solid neoplastic microenvironment and a well-documented factor attributable to therapeutic failure in clinical oncology. Low oxygen availability also plays a central role in the pathogenesis of major ischaemic disorders, such as acute myocardial infarction, stroke and preeclampsia.
Liu, Changjiang   +2 more
openaire   +2 more sources

Hypoxia-inducible MiR-210 is an independent prognostic factor and contributes to metastasis in colorectal cancer. [PDF]

open access: yesPLoS ONE, 2014
MicroRNA-210 (miR-210), the master hypoxamir, plays pleiotropic roles in certain cancers; however, its role in the development of human colorectal cancer remains unclear.
Ailin Qu   +13 more
doaj   +1 more source

miR-210 Regulates Apoptotic Cell Death during Cellular Hypoxia and Reoxygenation in a Diametrically Opposite Manner

open access: yesBiomedicines, 2021
Apoptotic cell death of cardiomyocytes is a characteristic hallmark of ischemia–reperfusion (I/R) injury. The master hypoxamiR, microRNA-210 (miR-210), is considered the primary driver of the cellular response to hypoxic stress.
Gurdeep Marwarha   +4 more
doaj   +1 more source

MicroRNA‐210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β‐catenin signaling pathway and EMT in esophageal squamous cell carcinoma

open access: yesThoracic Cancer, 2021
Evidence from previous studies showed that the dysregulation of microRNA (miR) is frequently associated with tumor progression. The aberrant miR‐210 expression has been identified in a variety of tumors.
Jing Meng   +5 more
doaj   +1 more source

Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer

open access: yesGastroenterology Research and Practice, 2020
Purpose. This study was aimed at investigating the roles of plasma miR-181b, miR-196a, and miR-210 in the diagnosis of pancreatic cancer (PC). Methods. Plasma samples were isolated from 40 patients with PC and 40 healthy individuals, respectively.
Gongpan Liu   +5 more
doaj   +1 more source

Hypoxia induces microRNA miR‐210 in vitro and in vivo [PDF]

open access: yesFEBS Letters, 2008
Shortage of oxygen is one of the prime stress conditions in tissues. In this study, we looked for microRNAs expressed during hypoxia and showed that miR‐210 expression was upregulated in response to hypoxia in vitro and in vivo. An active form of the HIF‐1α induced the expression of miR‐210, showing the involvement of the HIF‐1 signaling pathway in miR‐
Pulkkinen, Kati   +4 more
openaire   +2 more sources

Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation

open access: yesFrontiers in Molecular Biosciences, 2021
Gemcitabine (GEM) resistance remains a challenging clinical issue to overcome in chemotherapy against pancreatic cancer. We previously demonstrated that miR-210 derived from pancreatic cancer stem cells enhanced the GEM-resistant properties of pancreatic
Fei Xu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy